SY56 - From Bench to Bedside: Tools for Personalized Care in Adrenal Disorders

Symposium Chair(s)

• 

  Irina Bancos, MD, MS (she/her/hers)

  Consultant Endocrinologist, Professor of Medicine
  Division of Endocrinology, Diabetes, Metabolism and Nutrition
  Mayo Clinic Rochester
  Rochester, Minnesota, United States

  Disclosure(s): No financial relationships to disclose
• 

  Livia Mermejo, MD, PhD

  Assistant Professor
  Ribeirao Preto Medical School, University of Sao Paulo
  Ribeirao Preto, Brazil

  Disclosure(s): No financial relationships to disclose

This session covers cutting-edge research on biomarkers and their role in predicting outcomes and guiding treatment for adrenal disorders and neuroendocrine tumors. It includes discussions on survival prediction in adrenocortical carcinoma, the search for objective biomarkers in glucocorticoid replacement therapy for adrenal insufficiency, and the prediction of metastasis in pheochromocytoma and paraganglioma.

Presentations:

• 4:30 PM - 5:00 PM CT

  Glucocoricoid Replacement Therapy in Adrenal Insufficiency: Are There Any Objective Biomarkers?
  

  Symposium Speaker: Irina O. Chifu, MD (she/her/hers) – Universitaetsklinikum Wuerzburg
• 5:00 PM - 5:30 PM CT

  Biomarkers of survival and treatment response in adrenocortical carcinoma
  

  Symposium Speaker: Matthias Kroiss (he/him/his) – UNIVERSITY OF WUERZBURG
• 5:30 PM - 6:00 PM CT

  Bedside-Bench-Back: Personalised Drug Testing in PPGL
  

  Symposium Speaker: Katharina Wang, MD – LMU Hospital